A detailed history of Black Rock Inc. transactions in Alector, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,101,437 shares of ALEC stock, worth $44.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,101,437
Previous 8,483,565 7.28%
Holding current value
$44.7 Million
Previous $51.1 Million 19.09%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.19 - $6.23 $2.59 Million - $3.85 Million
617,872 Added 7.28%
9,101,437 $41.3 Million
Q1 2024

May 10, 2024

BUY
$5.69 - $8.08 $2.36 Million - $3.35 Million
415,012 Added 5.14%
8,483,565 $51.1 Million
Q4 2023

Feb 13, 2024

BUY
$3.77 - $8.39 $1.27 Million - $2.83 Million
337,575 Added 4.37%
8,068,553 $64.4 Million
Q3 2023

Nov 13, 2023

SELL
$5.2 - $8.77 $491,790 - $829,422
-94,575 Reduced 1.21%
7,730,978 $50.1 Million
Q2 2023

Aug 11, 2023

BUY
$5.86 - $7.93 $1.42 Million - $1.92 Million
241,637 Added 3.19%
7,825,553 $47 Million
Q1 2023

May 12, 2023

BUY
$5.85 - $9.84 $1.26 Million - $2.12 Million
215,296 Added 2.92%
7,583,916 $46.9 Million
Q4 2022

Feb 13, 2023

BUY
$6.88 - $9.55 $9.39 Million - $13 Million
1,365,044 Added 22.74%
7,368,620 $68 Million
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $1.47 Million - $2.36 Million
178,917 Added 3.07%
6,003,576 $56.8 Million
Q2 2022

Aug 12, 2022

BUY
$7.65 - $14.24 $3.48 Million - $6.47 Million
454,674 Added 8.47%
5,824,659 $59.2 Million
Q1 2022

May 12, 2022

SELL
$13.02 - $20.78 $135,720 - $216,610
-10,424 Reduced 0.19%
5,369,985 $76.5 Million
Q4 2021

Feb 10, 2022

BUY
$19.35 - $25.54 $2.12 Million - $2.8 Million
109,595 Added 2.08%
5,380,409 $111 Million
Q3 2021

Nov 09, 2021

BUY
$21.65 - $39.49 $1.84 Million - $3.36 Million
85,050 Added 1.64%
5,270,814 $120 Million
Q2 2021

Aug 11, 2021

BUY
$15.5 - $22.48 $80.4 Million - $117 Million
5,185,764 New
5,185,764 $108 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $405M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.